0.21
-4.65%
Close of 9 Nov 2026, in AUD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Singular Health Group
Its shares trade on ASX under the ticker SHG.AX. It has been listed since 12 February 2021. In the fiscal year to 30 June 2025, it reported revenue of A$702,000 and a net loss of A$6.4m. At that date it held total assets of A$14.2m and shareholders' equity of A$13.1m.
Singular Health Group Ltd. develops medical technology imaging products. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2021-02-12. The firm is focused on helping practitioners and patients via personalized surgical planning solutions that drive health outcomes. Its Volumetric Rendering Platform (VRP) leverages existing two-dimensional (2D) radiological images to generate fully immersive patient-specific three-dimensional (3D/VR) models. Its software products include 3DicomViewer, 3DicomVSP, GeoVR and Health Academy. 3Dicom Viewer is a cross-platform application which allows end-users to interact with standard 2D medical images, such as magnetic resonance imaging (MRI) and computerized tomography (CT) scans in 3D. Health Academy has been developed to focus primarily on the year 11 and year 12 Australian Tertiary Admissions Rank (ATAR) human biology courses. 3DicomVSP is a software that underpins the Scan to Surgery approach with the intuitive user-interface providing modules for each of the phases of 3D/VR scan review.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Technology
- Listed since
- 12 Feb 2021
- Website
- singular.health ↗
Leadership
Pay as last reported
- Mr. Howard DigbyNon-Executive Chairman of the BoardA$116,594
- Mr. Denning ChongChief Executive Officer, Managing Director, DirectorA$407,120
- Mr. Kyla GaricChief Financial Officer
- Mr. James HillChief Operating Officer, since 2021A$377,717
- Ms. Martina MarianoChief Commercial Officer
- Mr. Steven WoodJoint Company Secretary, since 2023A$239,736
- Mr. Andrew JustNon-Executive DirectorA$105,749
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Develops medical technology imaging products including Volumetric Rendering Platform (VRP).
- Offers personalized surgical planning solutions using 2D radiological images to create 3D/VR models.
- Software products include 3DicomViewer, 3DicomVSP, GeoVR, and Health Academy.
Weaknesses
- Health Academy focuses on Australian Year 11 and Year 12 ATAR human biology courses.
- No mention of financial performance or market share data provided.
- No details on competitive advantages or unique technology features beyond product names.
Opportunities
- Expanding use of 3D/VR models in surgical planning could increase market demand.
- Health Academy could potentially expand beyond Australian educational curricula.
- Growth in medical imaging technology sector may drive company expansion.
Threats
- Dependence on existing 2D radiological imaging systems for 3D model generation.
- Competition in medical imaging technology sector not detailed in provided information.
- Health Academy's limited focus on specific educational levels may restrict market reach.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.